PDCD1 and neoplasm: When they are exhausted, the continuous recruitment of a large number of peripheral blood lymphocytes into tumors for supplementing tumor infiltrating lymphocytes may be important for subsequent anti-PD-1 treatment responsiveness (22, 23).